Aliada, a housekeeping booking service based in Mexico City, is offering a new, socially responsible model for one of the most maligned segments of the on-demand economy. We didn’t want to look for ...

Chiesi has entered an exclusive licence agreement with Aliada Therapeutics, a subsidiary of AbbVie, to develop enzyme replacement therapies using blood-brain barrier (BBB)-crossing technology for ...

PARMA, Italy, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Chiesi Group today announced it has entered into an exclusive license agreement with Aliada Therapeutics, a wholly owned subsidiary of AbbVie, to ...

The Mexican startup Homely, a platform that links cleaning professionals with businesses, offices and homes, announced the acquisition of Aliada, its main competitor in domestic services to expand its ...

(RTTNews) - AbbVie, Inc. (ABBV) and biotechnology company Aliada Therapeutics announced Monday a definitive agreement under which AbbVie will acquire all outstanding Aliada equity for $1.4 billion in ...

AbbVie, an American pharmaceutical company headquartered in North Chicago, Illinois and Aliada Therapeutics announced a definitive agreement under which AbbVie will acquire Aliada, a biotechnology ...

This acquisition will bring Aliada’s Alzheimer’s treatment under AbbVie’s pipeline. AbbVie announced the completion of its acquisition of Aliada Therapeutics. 1 As a result, Aliada’s lead ...

AbbVie has made a big move in the Alzheimer’s space just a few months after it dropped its own internal candidate over the summer. On Monday, the pharma company announced a $1.4 billion acquisition of ...

AbbVie is buying Aliada Therapeutics for $1.4 billion. It is AbbVie’s third acquisition this year and its first in the neuroscience space since the firm bought Cerevel Therapeutics and its late-stage ...

NORTH CHICAGO, Ill. - In a move to expand its neuroscience portfolio, pharmaceutical giant AbbVie (NYSE: NYSE:ABBV) has announced the acquisition of biotech firm Aliada Therapeutics. The deal, valued ...